AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced the presentation of new preclinical data ...

In vitro, SBT-100 has shown beneficial effects against triple negative human breast cancer (MDA-MB-231) and human pancreatic cancer (PANC-1) at nanomolar concentrations. Treatment with SBT-100 ...

In this study, the anticancer mechanism was analyzed in MDA-MB-231 cells using MTT, lactate dehydrogenase, caspase, DNA fragmentation, clonogenic, flow cytometry, Western blot, and scratch assays.

Several students from the Southern Arkansas University College of Science and Engineering took part in the 108th annual Arkansas Academy of Science (AAS) Conference, held April 4–5 at Lyon College ...